Flexion Therapeutics
FLXN
#7221
Rank
NZ$0.78 B
Marketcap
NZ$15.67
Share price
0.00%
Change (1 day)
8,187.87%
Change (1 year)

Earnings for Flexion Therapeutics (FLXN)

Earnings in 2021 (TTM): -NZ$0.12 Billion

According to Flexion Therapeutics 's latest financial reports the company's current earnings are NZ$0.10 Billion. In 2020 the company made an earning of -NZ$0.17 Billion, an increase over its 2019 earnings that were of -NZ$0.23 Billion.

Earnings history for Flexion Therapeutics from 2013 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-NZ$0.12 Billion-29.16%
2020-NZ$0.17 Billion-29.78%
2019-NZ$0.23 Billion-13.8%
2018-NZ$0.27 Billion21.98%
2017-NZ$0.22 Billion79.92%
2016-NZ$0.13 Billion53.34%
2015-NZ$78.59 Million69.98%
2014-NZ$46.24 Million51.72%
2013-NZ$30.48 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$55.65 B-40,907.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$20.36 B-15,029.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
NZ$6.46 M-104.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pacira Biosciences
PCRX
NZ$71.86 M-152.69%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-NZ$17.68 Million-87.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Ampio Pharmaceuticals
AMPE
-NZ$14.83 Million-89.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-NZ$0.11 Billion-20.90%๐Ÿ‡บ๐Ÿ‡ธ USA